A University of Michigan study reveals that working overtime is driven by a desire to improve social status and cultivate a sense of belonging, rather than just financial gain. The research found that blue-collar workers who work overtime are motivated by the desire to consume luxury items and keep up with their white-collar counterparts.
Silverman's research focuses on inhibiting an enzyme that produces nitric oxide, a compound linked to high blood pressure, stroke, and neurological diseases. His work aims to block the overproduction of nitric oxide in the brain without affecting its normal function.
Kende has won the Arthur C. Cope Scholar Award for his work on rearrangement reactions, including discovering how dioxins relate to their toxic effects. He also recreated autoinducers, chemical signals that activate bacteria's growth or attack on the body.
A New York chemist has made groundbreaking discoveries in synthesizing molecules, including pharmaceuticals, using a novel approach. His research reveals the importance of controlling the 'handedness' of compounds and introduces new reactions using pseudoephedrine.
Chicago chemist Milan Mrksich has won a national award for his research on how cells communicate with the matrix proteins that anchor them to surfaces. His approach involves dissecting the complex system and creating simple mimics of the matrix to study in controlled experiments.
Researchers Robert Young, Robert J. Zamboni and Marc Labelle recognized for developing commercial products that improve children's health and wellness with Singulair asthma treatment.
A meta-analysis of nine community-based studies found that health workers can effectively manage pneumonia in the community, leading to a significant reduction in child mortality. The intervention resulted in a 24-36% decrease in total and pneumonia-specific child mortality rates, with a notable impact on neonates.
Researchers studied two binary star systems, predicting regular flare cycles similar to the Sun's magnetic cycle. The team used continuous monitoring of radio waves to discover patterns in flare strength, indicating active and inactive cycles every 50-120 days.
A renowned chemist has won a prestigious award for his groundbreaking work on creating molecules found in nature, including lapidilectine B. He developed a new method to build nitrogen ring structures and successfully recreated the molecule step-by-step in the laboratory.
A study suggests that women are more likely to turn to their GPs than the internet when seeking information about HRT. Despite increased access to health information online, many women lack 'information literacy' and struggle to navigate online resources.
Teams from Abbott, Merck, Pfizer, and Wyeth Pharmaceuticals have developed commercial products based on chemistry to improve children's health and wellness. These products include Kaletra, Singulair, Neurontin, and Prevnar, which have advanced the health and well-being of children worldwide.
Purdue University chemist Jean Chmielewski has won a national award for developing new compounds that disrupt the AIDS virus's ability to reproduce. Her approach involves creating molecular 'wedges' that block HIV proteins from binding together, promising initial results in testing with infected cells.
Seyferth's research focuses on creating new molecules through the use of organometallic compounds. He has made significant contributions to the field of organometallic chemistry, including the development of methods for synthesizing complex compounds such as drugs and adhesives.
The American Academy of Ophthalmology has awarded Special Recognition Awards to Mr. McManus for his dedication to vision research, and Dr. Jones and Dr. Brown for their innovative research and humanitarian efforts. The awards recognize their contributions to the field of ophthalmology.
Dr. Rawal has developed a rapid and straightforward reaction that can assemble pieces of complex molecules with high accuracy. This innovation is expected to improve the performance of anticancer drugs like vincristine, which has been used successfully in treating childhood leukemia.
Two collaborative research projects on drug addiction and postpartum depression have been awarded funding. The studies will investigate sex-based differences in gene expression and the effect of estrogen on treatment response.
Dale J. Kempf, Daniel W. Norbeck, and Hing L. Sham receive award for developing Kaletra, the first HIV protease inhibitor approved for use in children as young as six months old.
Researchers create experimental model of a non-equilibrium system to test the soundness of temperature in a continuously shaken container of tiny beads. They find that temperature follows the expected rules, suggesting that essential information can be extracted from disordered motion in dissipative systems.
A chemist's research creates tools to make complex drugs more efficiently, with potential breakthroughs in anti-cancer treatments. His work has led to licenses for pharmaceutical companies to study promising drug candidates.
The Wyeth Pharmaceuticals team is being recognized for their role in developing the first combined pneumococcal vaccine for infants, Prevnar. The vaccine has dramatically advanced the health and well-being of children worldwide by preventing serious diseases such as meningitis, bacteremia, and pneumonia.
A renowned chemist has synthesized epothilone, a compound derived from bacteria, promising to replace taxol in treating cancer. His successful 25-step synthesis has garnered interest from pharmaceutical companies, paving the way for potential clinical trials and widespread use.
The Pfizer Inc team won the Heroes of Chemistry award for developing Neurontin, a medication controlling seizures in children. This breakthrough led to improved quality of life for many children with epilepsy, demonstrating the valuable role chemists play in improving lives.
The American Academy of Ophthalmology is honoring Dr. Demorest, Dr. Scott, and Dr. Stambaugh for their significant contributions to ophthalmology. They are recognized for their clinical, educational, and research achievements, as well as their leadership positions in the field.
The UGA research team has identified a molecular key to cell division, which could lead to new targets for cancer therapeutics. The study found that cyclin-dependent kinases drive the mitosis process and that molecules called oncogenes and tumor suppressor genes are controlled by novel mechanisms.
Researchers have discovered that microRNAs play a crucial role in controlling plant growth and development by regulating cell division and leaf shape. The study found that a specific microRNA called "Jaw" targets messenger RNAs involved in preventing excessive cell division, leading to abnormal leaf shapes.